Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Sanofi Acquires Ablynx for $4.85 Billion

One week after Sanofi agreed to buy Waltham, Mass.-based Bioverativ for $11.6 billion, the French drugmaker announced the acquisition of Ghent, Belgium-based Ablynx for about $4.85 billion.

Read More »

Scientists use pocket-size device to map human genetic coder

Scientists have assembled the most complete human genome to be mapped with a single technology using a new pocket-size portable DNA sequencer, which they say could one day make genome mapping quick and simple enough to do at home.

Read More »

Takeda’s Zika vaccine gets U.S. FDA’s ‘fast track’ status

Japan’s Takeda Pharmaceutical Co. Ltd. said on Monday the U.S. Food and Drug Administration granted ‘fast track’ status to its vaccine for the mosquito-borne Zika virus.

Read More »

Chugai’s Hemlibra Gains Positive CHMP Opinion

The EU’s CHMP adopted a positive opinion for Hemlibra (emicizumab) for routine prophylaxis of bleeding episodes in people with hemophilia A with factor VIII inhibitors.

Read More »

AbbVie wins U.S. trial in lawsuit over AndroGel’s risks

A federal jury found AbbVie not liable in a lawsuit by an Arizona man who claimed he suffered a pulmonary embolism due to using the company’s testosterone replacement medication AndroGel.

Read More »

U.S. SEC files suit over possible insider trading on Bioverativ

The U.S. Securities and Exchange Commission filed an insider trading lawsuit against “unknown traders” who it said engaged in “highly suspicious trading” just ahead of the announcement that hemophilia specialist Bioverativ Inc. agreed to be acquired by France’s Sanofi in an $11.6 billion deal.

Read More »

Outcome Health Announces Settlement To Reinvest In Its Future

Outcome Health, a Chicago-based company that provides health education technology to improve patient outcomes at physician practices nationwide, announced that it has settled all litigation with its investors.

Read More »

Novelion to Cut Jobs in Restructuring

Following a disappointing 2017 that included an agreement to pay $40 million to resolve criminal charges against its subsidiary Aegerion, Canada-based Novelion Therapeutics will slash an unknown number of jobs as it initiates “significant cost reduction plans.”

Read More »

FDA approves drug for digestive tract cancer

The U.S. Food and Drug Administration approved French drugmaker Advanced Accelerator Application SA’s drug to treat patients with a type of digestive tract cancer.

Read More »

J&J Reportedly Bows Out of Race for Pfizer’s Consumer Health Business

Industry insiders say Johnson & Johnson is no longer interested in Pfizer’s $20 billion consumer healthcare business

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

October 2018 Focus: Top 50 Pharma, Company of the Year and more!


Ad Right Bottom